Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Hybridoma Technology01:31

Hybridoma Technology

14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
Combinatorial Gene Control02:33

Combinatorial Gene Control

8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
CRISPR and crRNAs02:53

CRISPR and crRNAs

16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facile Access to Functional Polymer Materials via Living Lewis Pair Polymerization and Post-Polymerization Modification.

Polymer science & technology (Washington, D.C.)·2026
Same author

Spatiotemporal regulation of neutrophil-mediated immune cascades via engineered PEEK surfaces restores osseointegration in diabetes.

Bioactive materials·2026
Same author

Licochalcone A targets ADRB2 to enhance CD8<sup>+</sup> T cell anti-leukemia activity via regulation involving the AKT2/FOXO1/GLUT2 axis.

Pathology, research and practice·2026
Same author

Cyanobacteria-derived near-infrared autofluorescent exosomes enabling synergistic brain lesion imaging and neuroprotection.

Bioactive materials·2026
Same author

Targeting adipocyte ESRRA alleviates osteoarthritis via interrupting inter-organelle crosstalk of complement C3-CFD-MAC cascade.

Bone research·2026
Same author

Immune-activating PTL/nanowire composite coating on Ti surface enables macrophage-driven bacterial clearance and osseointegration.

Bioactive materials·2026

Related Experiment Video

Updated: Jun 12, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.5K

Artificial intelligence-driven circRNA vaccine development: multimodal collaborative optimization and a new paradigm

Yan Zhao1, Huaiyu Wang1

  • 1Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, P.R. China.

Briefings in Bioinformatics
|June 8, 2025
PubMed
Summary

Circular RNA (circRNA) vaccines offer enhanced stability and reduced immune response compared to linear mRNA vaccines. Artificial intelligence (AI) is accelerating the design and optimization of these next-generation vaccines.

Keywords:
artificial intelligencebioinformatics AIcircRNA vaccinedeep learninggenerative AI

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Related Experiment Videos

Last Updated: Jun 12, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.2K

Area of Science:

  • Biotechnology
  • Immunology
  • Bioinformatics

Background:

  • Circular RNA (circRNA) vaccines present a novel platform for infectious disease prevention and cancer immunotherapy.
  • They offer improved molecular stability and reduced immunogenicity over conventional linear messenger RNA (mRNA) vaccines.
  • circRNA vaccines leverage their unique structure to enhance stability and minimize innate immune activation.

Purpose of the Study:

  • To explore the role of Artificial Intelligence (AI) in advancing circRNA vaccine development.
  • To evaluate the effectiveness of AI-driven approaches in optimizing circRNA vaccine design and delivery.
  • To identify challenges and propose a hybrid paradigm for future circRNA vaccine research.

Main Methods:

  • Application of deep learning models (CNNs, Transformers) for antigen prediction and RNA structure modeling.
  • Integration of multi-omics data for refining vaccine components and delivery systems.
  • Utilizing generative AI for literature synthesis and experimental planning.

Main Results:

  • AI significantly enhances accuracy and efficiency in antigen screening and delivery system formulation compared to traditional methods.
  • Generative AI accelerates research planning but faces challenges with reference reliability and biological interpretability.
  • A hybrid AI-traditional-experimental approach is proposed to overcome limitations.

Conclusions:

  • AI, particularly deep learning, is revolutionizing circRNA vaccine design, offering superior performance.
  • Challenges like AI's 'black-box' nature and literature retrieval issues necessitate a combined approach.
  • Future research requires mechanism-driven AI, experimental validation, and ethical oversight for clinical translation.